Cristina Motlló

发表

Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+ cell dose

J. Sancho, J. Juncà, J. Ribera, 2017, Leukemia & lymphoma.

Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old.

J. Sancho, J. Juncà, J. Ribera, 2014, Cytotherapy.

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome

E. González-Barca, S. Mercadal, J. Sancho, 2017, Hematological oncology.

Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)

F. Bosch, P. Abrisqueta, J. Delgado, 2020, British journal of haematology.

New drugs for follicular lymphoma.

J. Sancho, J. Ribera, M. Sorigué, 2016, Leukemia research.

Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?

A. Oriol, J. Ribera, C. Motlló, 2019, Clinical lymphoma, myeloma & leukemia.

Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

F. Prósper, S. Fudio, A. Oriol, 2016, Cancer medicine.

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols

M. Tormo, J. Cervera, S. Brunet, 2017, Leukemia & lymphoma.

Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk‐adapted protocols

M. Tormo, J. Hernández-Rivas, J. Cervera, 2014, Cancer.

Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients

A. Altés, C. Motlló, M. Constans, 2021, Thrombosis Research.

Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas.

J. Bladé, L. Rosiñol, M. Gironella, 2022, Clinical lymphoma, myeloma & leukemia.

Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia

S. Mercadal, M. Tormo, J. Hernández-Rivas, 2018, Leukemia & lymphoma.

Blinatumomab for treating acute lymphoblastic leukemia

J. Ribera, C. Motlló, S. Vives, 2015 .

Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old.

J. Sancho, J. Juncà, J. Ribera, 2014, Cytotherapy.

Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group

A. Oriol, E. Ocio, J. San-Miguel, 2020, British journal of haematology.